These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 25803136)

  • 1. Adjunctive Valproic Acid in Management-Refractory Hyperactive Delirium: A Case Series and Rationale.
    Sher Y; Miller AC; Lolak S; Ament A; Maldonado JR
    J Neuropsychiatry Clin Neurosci; 2015; 27(4):365-70. PubMed ID: 25803136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valproic Acid for Treatment of Hyperactive or Mixed Delirium: Rationale and Literature Review.
    Sher Y; Miller Cramer AC; Ament A; Lolak S; Maldonado JR
    Psychosomatics; 2015; 56(6):615-25. PubMed ID: 26674479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of Huntington's disease with olanzapine and valproate.
    Grove VE; Quintanilla J; DeVaney GT
    N Engl J Med; 2000 Sep; 343(13):973-4. PubMed ID: 11012330
    [No Abstract]   [Full Text] [Related]  

  • 4. Valproic Acid for the Management of Agitation and Delirium in the Intensive Care Setting: A Retrospective Analysis.
    Crowley KE; Urben L; Hacobian G; Geiger KL
    Clin Ther; 2020 Apr; 42(4):e65-e73. PubMed ID: 32273047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproic Acid in the Management of Delirium.
    Cuartas CF; Davis M
    Am J Hosp Palliat Care; 2022 May; 39(5):562-569. PubMed ID: 34409869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risperidone as an adjunct to valproic acid.
    Waring EW; Dewan VK; Cohen D; Grewal R
    Can J Psychiatry; 1999 Mar; 44(2):189. PubMed ID: 10097843
    [No Abstract]   [Full Text] [Related]  

  • 7. [Good effect of valproate against aggression in Huntington disease. Only two cases reported earlier].
    Rask G; Andersson C
    Lakartidningen; 2010 Dec 1-7; 107(48):3060-1. PubMed ID: 21287753
    [No Abstract]   [Full Text] [Related]  

  • 8. Prolonged Refractory ICU Delirium Successfully Treated With Valproic Acid: Case Report and Literature Review.
    Subedi B; Louzon PR; Masood A; Recksieck S
    J Pharm Pract; 2021 Dec; 34(6):984-987. PubMed ID: 32912027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delirium and persistent dyskinesia induced by a lithium-neuroleptic interaction.
    Normann C; Brandt C; Berger M; Walden J
    Pharmacopsychiatry; 1998 Sep; 31(5):201-4. PubMed ID: 9832353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation of clozapine with valproic Acid for clozapine-induced obsessive-compulsive symptoms.
    Zink M; Englisch S; Knopf U; Kuwilsky A; Dressing H
    Pharmacopsychiatry; 2007 Sep; 40(5):202-3. PubMed ID: 17874353
    [No Abstract]   [Full Text] [Related]  

  • 11. Paliperidone extended-release as adjunctive therapy to lithium or valproate in the treatment of acute mania: a randomized, placebo-controlled study.
    Berwaerts J; Lane R; Nuamah IF; Lim P; Remmerie B; Hough DW
    J Affect Disord; 2011 Mar; 129(1-3):252-60. PubMed ID: 20947174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproate and neuroleptic medication.
    Reutens S; Castle D
    Br J Psychiatry; 1997 May; 170():484-5. PubMed ID: 9307707
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful antimanic treatment and mood stabilization with lamotrigine, clozapine, and valproate in a bipolar patient after lithium-induced cerebellar deterioration. A case report.
    Dembowski C; Rechlin T
    Pharmacopsychiatry; 2003; 36(2):83-6. PubMed ID: 12734768
    [No Abstract]   [Full Text] [Related]  

  • 14. Diabetic ketoacidosis with clozapine treatment.
    Maule S; Giannella R; Lanzio M; Villari V
    Diabetes Nutr Metab; 1999 Apr; 12(2):187-8. PubMed ID: 10554900
    [No Abstract]   [Full Text] [Related]  

  • 15. The effectiveness of high-dosage amisulpride combined with moderate-dosage sodium valproate treatment for an overweight patient with psychotic bipolar disorder.
    Hou YC; Lai CH
    J Neuropsychiatry Clin Neurosci; 2014 Apr; 26(2):E34-5. PubMed ID: 24763785
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapeutic evidence for manic episode].
    Terao T
    Seishin Shinkeigaku Zasshi; 2011; 113(9):867-72. PubMed ID: 22117391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rational use of medications in acute psychotic presentations -- the case for less is more.
    Awad AG
    J Psychiatry Neurosci; 2006 May; 31(3):216. PubMed ID: 16699606
    [No Abstract]   [Full Text] [Related]  

  • 18. Prescribing Practices of Valproic Acid for Agitation and Delirium in the Intensive Care Unit.
    Quinn NJ; Hohlfelder B; Wanek MR; Duggal A; Torbic H
    Ann Pharmacother; 2021 Mar; 55(3):311-317. PubMed ID: 32748626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between antimanic agent for treatment of classic or dysphoric mania and length of hospital stay.
    Frye MA; Altshuler LL; Szuba MP; Finch NN; Mintz J
    J Clin Psychiatry; 1996 Jan; 57(1):17-21. PubMed ID: 8543542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervical dystonia due to interaction of valproic acid and quetiapine.
    Habermeyer B; Rabovsky K; Jentzsch C; Pinhard K; Müller-Spahn F
    J Clin Psychopharmacol; 2007 Aug; 27(4):396-7. PubMed ID: 17632227
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.